Solid Biosciences

📍 Boston, United States🗓 Founded 2013👥 131 employees💰 Last funded Oct 2013
Biotechnology Research🌐 solidbio.com
Website LinkedIn
Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs for the treatment of devastating diseases, including Duchenne, Friedreich’s ataxia, BAG3 mediated dilated cardiomyopathy, and additional cardiac diseases. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients. Solid is headquartered in Charlestown, MA, USA.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2013
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Solid Biosciences?
Solid Biosciences has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Solid Biosciences last raise funding?
The most recent investment in Solid Biosciences recorded on gritt.io was in October 2013.
When was Solid Biosciences founded?
Solid Biosciences was founded in 2013.
What industry is Solid Biosciences in?
Solid Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Solid Biosciences based?
Solid Biosciences is headquartered in Boston, United States.